Hanlim Pharm Co., Ltd.

ACTIVE

1656-10 Seocho 1(il)-dong, Seocho-gu, Seoul, 首尔特别市, South Koreahanlim.comPrivate251–500 employeesEstablished: 1989-03-14

Also known as:

hanlim pharm. co., ltd._seoul office

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1989

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

43.1%

Phase 3

23.5%

Phase 2

11.8%

Phase 4

7.8%

Trial Status Distribution

Active, not recruiting

3.9%

Completed

68.6%

Recruiting

15.7%

Unknown

11.8%

Clinical Trials

Trials sponsored by this organization (51)

Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State

Phase 1

Completed

interventional

Oct 202437 participants

Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects

Phase 1

Completed

interventional

Nov 202336 participants

Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.

Phase 1

Completed

interventional

Oct 202330 participants

Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection

Recruiting

observational

Jul 20231,500 participants

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers

Phase 1

Completed

interventional

Jun 202335 participants

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

Phase 2

Recruiting

interventional

Jun 202396 participants

S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement

Recruiting

observational

Feb 20235,000 participants

Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops

Recruiting

observational

Feb 20232,000 participants

Page 1 of 7

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

Recent Approvals

Effexin Otic Solution 3 mg/ml

News

No news articles found

Back to Organizations